Pharma News, Research & Solutions CSR News

Harris Poll Survey Offers Insights into Potential of Telepsychiatry During and After the COVID-19 Pandemic

A Majority of Respondents Managing Mental Health Conditions Welcome Telepsychiatry Option to Support Continuity of, and Access to, Mental Health Care
Article

As the use of telehealth services has expanded during the COVID-19 pandemic, results from a survey conducted by The Harris Poll showed that more than one in four (27%) U.S. adults surveyed were currently using telepsychiatry (“telepsych”) services for mental health care.

Facing Pandemics and Emerging Threats, ATMP Industry Arrives at Intersection of Obstacle and Opportunity

CRB report explores challenges and solutions as cell and gene therapy organizations confront new urgency for patient therapies
Press Release

KANSAS CITY, Mo., Oct. 28, 2020 /3BL Media/ – From the global COVID-19 pandemic to rare and challenging health threats, our world seems forever on the defense against disease and in need of a nimble and efficient vaccine and therapy supply chain. But a new report from CRB, a leading global provider of biopharma manufacturing solutions, spotlights the critical conflicts threatening the speedy delivery of patient therapies.

4 Ways Johnson & Johnson Is Cultivating Outside-the-Box Innovations for COVID-19

By Jennifer Rainey Marquez
Summary: 

In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.

Article

In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.

Department of Defense Study Finds Risk of Exposure To COVID-19 Is Almost Non-Existent on United Flights

Multimedia with summary

The results are in: Your risk of exposure to COVID-19 is almost non-existent on our flights (yes, even on a full flight). 

Learn more about the robotic mannequins, biodefense sensors and the results of this U.S. Department of Defense study here.

About United

Medtronic Donates Nearly $1 Million in Personal Protective Equipment to International Medical Corps for COVID-19 Response Efforts

In Partnership with the Medtronic Foundation, More Than 400,000 KN95 Respirators and 1.1 Million Surgical Masks to be Distributed to Healthcare Facilities Across Continental U.S. and Puerto Rico
Press Release

DUBLIN, October 9, 2020 /3BL Media/ - Medtronic, the global leader in medical technology, today announced that it has donated nearly $1 million worth of personal protective equipment (PPE) to relief organization International Medical Corps to support its ongoing COVID-19 response efforts in the continental United States and Puerto Rico.

Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19

Summary: 

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

Article

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

By Liz Ozaist, Global Content Lab Editor-in-Chief, Johnson & Johnson
Summary: 

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

Blog

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines

CRB, a leader in the design and construction of biotech manufacturing facilities, creates SlateXpace – a multimodal facility solution that delivers unmatched industry speed, flexibility and adaptability for the advanced therapy market
Press Release

SAN DIEGO, Calif., Sept. 30, 2020 /3BL Media/ – Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.

Pages

Subscribe to Pharma News, Research & Solutions